Work

Prevalence Rates of Pneumococcal Vaccination in IBD and 30-Day Clinical Outcomes in Patients With IBD and Pneumococcal Disease Stratified by Receipt of Pneumococcal Vaccination: A Multi-Network Study

Year: 2023

Type: article

Study design: Observational Study

Abstract: Lay Summary This study sought to assess outcomes associated with pneumococcal vaccination in adult inflammatory bowel disease patients. Results found unvaccinated patients had higher adverse outcomes, including greater risk of hospitalization, ICU admission, ventilation, and mortality. These findings underscore the importance of pneumococcal vaccination.

Source: Crohn s & Colitis 360

DOI: 10.1093/crocol/otad048

Authors: Andrew Ford, Vibhu Chittajallu, Jaime Abraham Perez, Scott Martin, Motasem Alkhayyat, Maneesh Dave, Edith Y Ho, Preetika Sinh, Vu Nguyen, Gregory Cooper, Jeffry Katz, Fabio Cominelli, Miguel Regueiro, Emad Mansoor

Institutions: Cleveland Clinic, University Hospitals Cleveland Medical Center, Case Western Reserve University, University Hospitals of Cleveland, University of California Davis Medical Center, Stanford Medicine, Stanford University, Medical College of Wisconsin

Language: English

Topic: Pneumonia and Respiratory Infections

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,064

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Award: The Cleveland Digestive Diseases Research Core Center (DDRCC)

OpenAlex ID: W4389471936

FWCI: 0.499

Cites: 13

Cited by: 3

Related to: 10